Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions

被引:0
|
作者
Masahiro Okada
Taro Shimono
Yoshihiro Komeya
Rina Ando
Yuki Kagawa
Takashi Katsube
Masatomo Kuwabara
Yukinobu Yagyu
Seishi Kumano
Izumi Imaoka
Norio Tsuchiya
Ryuichiro Ashikaga
Makoto Hosono
Takamichi Murakami
机构
[1] Kinki University School of Medicine,Department of Radiology
来源
关键词
Adrenal gland; Adrenal tumor; FDG-PET/CT; SUV; CT attenuation value;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:349 / 354
页数:5
相关论文
共 50 条
  • [21] Fluorodeoxyglucose positron emission tomography/computed tomography standardized uptake value in discriminating benign versus malignant lesions: an open and debated issue
    Bertagna, Francesco
    Giubbini, Raffaele
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (06) : 542 - 543
  • [22] The diagnostic value of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET/CT) for urachal cancer
    Stokkel, L. E.
    Stokkel, M. P.
    Donswijk, M. L.
    Lahaye, M. J.
    Van Rhijn, B. W. G.
    Mertens, L.
    EUROPEAN UROLOGY, 2021, 79 : S963 - S964
  • [23] The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the Literature
    Ili Margalit
    Anat Yahav
    Yaara Ben Ari
    Haim Ben-Zvi
    Avivit Shoham
    Elad Goldberg
    Michal Weiler-Sagie
    Noam Tau
    Khitam Muhsen
    Jihad Bishara
    Mical Paul
    Hanna Bernstine
    Dafna Yahav
    Infectious Diseases and Therapy, 2021, 10 : 2227 - 2246
  • [24] The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the Literature
    Margalit, Ili
    Yahav, Anat
    Ben Ari, Yaara
    Ben-Zvi, Haim
    Shoham, Avivit
    Goldberg, Elad
    Weiler-Sagie, Michal
    Tau, Noam
    Muhsen, Khitam
    Bishara, Jihad
    Paul, Mical
    Bernstine, Hanna
    Yahav, Dafna
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2227 - 2246
  • [25] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    CANCER, 2009, 115 (21) : 5038 - 5047
  • [27] The value of F-18-fluorodeoxyglucose positron emission tomography (FDG-PET/CT) in the intensive care unit: a review
    van Hulst, A. M.
    van Rijk, M. C.
    Bavelaar-Croon, C. D. L.
    Tjan, D. H. T.
    NETHERLANDS JOURNAL OF CRITICAL CARE, 2019, 27 (03): : 108 - 114
  • [28] Indeterminate pulmonary nodules on Computed Tomography (CT) images in breast cancer (BC) patient: the additional value of 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/CT
    Evangelista, L.
    Panunzio, A.
    Cervino, A. R.
    Vinante, L.
    Rubello, D.
    Polverosi, R.
    Gregianin, M.
    Saladini, G.
    Muzzio, P. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S449 - S450
  • [29] Recurrence detection by Fluorodeoxyglucose (FDG) and Positron Emission Tomography (PET)/Computed Tomography (CT) in risk categories of breast cancer
    Evangelista, L.
    Cervino, A. R.
    Vinante, L.
    Zago, G.
    Ghiotto, C.
    Bozza, F.
    Burei, M.
    Gregianin, M.
    Saladini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S283 - S283
  • [30] Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer
    Thrall, Melissa M.
    DeLoia, Julie A.
    Gallion, Holly
    Avril, Norbert
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 17 - 22